author-photo

Shu-Pang Huang

Bristol-Myers Squibb

25

Papers

949

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors.

2020 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (97)
Serum interleukin 8 (IL-8) may serve as a biomarker of response to immuno-oncology (I-O) therapy.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A Review of Daclatasvir Drug-Drug Interactions

2016 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (16)
Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

2016 Liver International
Show All
- Source
- Cite
- Save
Citations (20)
Effect of Ribavirin on the Safety Profile of Daclatasvir Plus Sofosbuvir for Patients With Chronic HCV Infection: Presidential Poster: 577

2014 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

2014 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (186)
The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus

2014 Clinical Drug Investigation
Show All
- Source
- Cite
- Save
Citations (18)
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat

2013 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (12)
Pharmacokinetics of the NS3 Protease Inhibitor, Asunaprevir (ASV, BMS‐650032), in Phase I Studies in Subjects With or Without Chronic Hepatitis C

2013 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (17)
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.

2012 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (77)